Alector, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Alector, Inc. (ALEC) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 82.10 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-05
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 82.10M shares, a 3.42% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 79.39M shares, a 6.10% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 79.01M shares, a 16.29% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 78.77M shares, a 16.57% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 80.42M shares, a 3.42% increase from fiscal 2020.
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 77.76M shares, a 25.96% increase from fiscal 2019.
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 61.73M shares, a 446.19% increase from fiscal 2018.
- Alector, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 11.30M shares, a 23.63% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 82.10M shares 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | 80.42M shares 10-K · filed 2022-02-24 | |||
| 2021-03-31 | 79.39M shares 10-Q · filed 2022-05-05 | 79.20M shares derived: average of 2 quarters · filed 2022-05-05 | 79.06M shares derived: average of 3 quarters · filed 2022-05-05 | 78.90M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 79.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 78.89M shares derived: average of 2 quarters · filed 2022-02-24 | 78.73M shares derived: average of 3 quarters · filed 2022-02-24 | 77.76M shares 10-K · filed 2022-02-24 |
| 2020-09-30 | 78.77M shares 10-Q · filed 2020-11-10 | 78.59M shares derived: average of 2 quarters · filed 2021-08-03 | 77.34M shares 10-Q · filed 2020-11-10 | 74.99M shares derived: average of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | 78.42M shares 10-Q · filed 2021-08-03 | 76.62M shares 10-Q · filed 2021-08-03 | 73.73M shares derived: average of 3 quarters · filed 2022-02-24 | 72.19M shares derived: average of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | 74.82M shares 10-Q · filed 2021-05-05 | 71.38M shares derived: average of 2 quarters · filed 2022-02-24 | 70.11M shares derived: average of 3 quarters · filed 2022-02-24 | 69.42M shares derived: average of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | 67.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 67.76M shares derived: average of 2 quarters · filed 2022-02-24 | 67.62M shares derived: average of 3 quarters · filed 2022-02-24 | 61.73M shares 10-K · filed 2022-02-24 |
| 2019-09-30 | 67.57M shares 10-Q · filed 2020-11-10 | 67.45M shares derived: average of 2 quarters · filed 2020-11-10 | 59.66M shares 10-Q · filed 2020-11-10 | 47.62M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | 67.33M shares 10-Q · filed 2020-08-11 | 55.64M shares 10-Q · filed 2020-08-11 | 40.97M shares derived: average of 3 quarters · filed 2021-02-25 | 33.59M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | 43.83M shares 10-Q · filed 2020-05-13 | 27.79M shares derived: average of 2 quarters · filed 2021-02-25 | 22.34M shares derived: average of 3 quarters · filed 2021-02-25 | 19.54M shares derived: average of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | 11.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 11.59M shares derived: average of 2 quarters · filed 2021-02-25 | 11.45M shares derived: average of 3 quarters · filed 2021-02-25 | 11.30M shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 11.44M shares 10-Q · filed 2019-11-12 | 11.30M shares derived: average of 2 quarters · filed 2019-11-12 | 11.15M shares 10-Q · filed 2019-11-12 | |
| 2018-06-30 | 11.16M shares 10-Q · filed 2019-08-12 | 11.01M shares 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | 10.86M shares 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | 9.14M shares 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |